On February 1st, implementation of the drug price law begins: We are aware that the beginning will be problematic

While in communiques have said they are aware that there will be problems at the beginning of implementation,

We are aware that the beginning will not be easy, there will be challenges, but we are committed to the long-term benefits of all, with particular emphasis on our citizens. To ensure respect for the law, as well as protecting the interests of patients, but other parties involved, the pharmaceutical Inspectorate will be fully committed, to monitor and implement this legislative reform”, the communiqué says.

The next week's “will start the deadlines for medical product prices, including medical products that have been registered for the first time. So we invite all interested parties to cooperate in this process, for a more fair and sustainable pharmaceutical market for all. The Health Ministry will be fully committed to implementing this legislative change to be easier and to overcome the eventual challenges we can face during implementation”, the announcement concludes.